476 related articles for article (PubMed ID: 16922945)
1. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
[TBL] [Abstract][Full Text] [Related]
2. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
3. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma in the Maltese Islands: 2000-2004.
Dalmas M; England K; Boffa MJ; Degaetano J; Gatt P
Eur J Cancer; 2007 Jul; 43(10):1604-10. PubMed ID: 17532206
[TBL] [Abstract][Full Text] [Related]
5. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
6. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
7. [Prospective epidemiological study on cutaneous melanomas in the Vendée area].
Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1121-4. PubMed ID: 14724514
[TBL] [Abstract][Full Text] [Related]
8. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
9. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
10. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Kittler H; Binder M; Wolff K; Pehamberger H
Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
[TBL] [Abstract][Full Text] [Related]
11. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
12. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
Coté TR; Sobin LH
Melanoma Res; 2009 Feb; 19(1):58-60. PubMed ID: 19430407
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous malignant melanomas in New Caledonia. Study of the Cancer Registry (1977-1987)].
Di Schino M; Merouze F; Huerre M; Grimaldi F; Lorthioir JM; Breda Y; Merrien Y
Med Trop (Mars); 1989; 49(3):271-6. PubMed ID: 2811654
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
[TBL] [Abstract][Full Text] [Related]
15. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years.
Ragnarsson-Olding BK; Nilsson PJ; Olding LB; Nilsson BR
Acta Oncol; 2009; 48(1):125-31. PubMed ID: 18607861
[TBL] [Abstract][Full Text] [Related]
16. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
[TBL] [Abstract][Full Text] [Related]
18. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
20. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
